{"nct_id":"NCT00596804","title":"Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma","status":"COMPLETED","status_verified_date":"2012-02","start_date":"2004-03","start_date_type":null,"primary_completion_date":"2007-11","primary_completion_date_type":"ACTUAL","completion_date":"2007-11","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}